Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fexofenadine vs Gabapentin for Uremic Pruritus
NCT06466421Phase 4Completed
- Sponsor
- Tanta University
- Start
- Jul 2024
- Primary completion
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of fexofenadine in uremic pruritus (2 arms), sponsored by Tanta University. Primary endpoints: Visual Analogue Scale at 3 months, Skindex score at 3 months and 1 more. Started Jul 2024; status: completed.
02
Drugs
fexofenadine
03
Conditions
uremic pruritus
Beyond the preview
Go deeper on NCT06466421.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06466421.